Akèy › Ipèsansibilite arachid › Texas
Etid klinik pou Ipèsansibilite arachid nan Texas
4 etid pou Ipèsansibilite arachid ap chèche patisipan nan sit nan Texas.
Tèks ofisyèl etid la (Anglè)
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
- Western Sky Medical Research, El Paso
Ap rekriteFaz 3
Laj 12 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07768371Efficacy of Tezepelumab in Peanut Oral Immunotherapy
- University of Texas Southwestern Medical Center: Division of Allergy and Immunology, Dallas
Ap rekriteFaz 2
Laj 12 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT07015996Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
- Children's Health, Dallas
- Texas Children's Hospital/Baylor College of Medicine, Houston
Ap rekriteFaz 1Volontè an sante akeyi
Laj 12 a 55 · Tout sèks · Mizajou Aug 25, 2026 · NCT07287033Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
- Dell Children's Medical Group, Austin
- Texas Children's Hospital, Houston
Ap rekriteFaz 2
Laj 12 a 55 · Tout sèks · Mizajou Jul 28, 2026 · NCT07220811Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.